Transfusion Clinical Trials in Tianjin, Tianjin Municipality
7 recruitingTianjin, Tianjin Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
Platelet Transfusion Refractoriness
Keymed Biosciences Co.Ltd110 enrolled1 locationNCT06792019
Recruiting
Phase 2
Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.
Allergic Transfusion Reaction
Institute of Hematology & Blood Diseases Hospital, China6,642 enrolled4 locationsNCT04688736
Recruiting
Not Applicable
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
Transfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China3 enrolled1 locationNCT06219239
Recruiting
Phase 1Phase 2
Β-Thalassemia Treatment with KL003 Cell Injection
Transfusion Dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.41 enrolled2 locationsNCT06280378
Recruiting
Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Pre-EclampsiaHigh Risk PregnancyTwin Pregnancy, Antepartum Condition or Complication+5 more
Peking University Third Hospital2,000 enrolled11 locationsNCT06414655
Recruiting
Phase 2
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06254560
Recruiting
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
Gene TherapyTransfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China100 enrolled1 locationNCT05991336